Viewing data from:

DOXYCYCLINE

ANDA

DOXYCYCLINE | A204234 | LUPIN LTD

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: MONODOX(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.2349

per ea

Lowest NADAC/Unit

$0.1559

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
68180065208DOXYCYCLINE MONO 100 MG CAP	$0.2349	EA	Generic	—	2026-06-17
68180065001DOXYCYCLINE MONO 50 MG CAP	$0.1559	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs8 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

HOVIONE FARMACIENCIA SADOXYCYCLINE MONOHYDRATE

DMF 137101998

YANGZHOU LIBERTY PHARMACEUTICAL CO LTDDOXYCYCLINE MONOHYDRATE

DMF 139441999

CHANGZHOU PHARMACEUTICAL FACTORYDOXYCYCLINE

DMF 189592005

HOVIONE FARMACIENCIA SADOXYCYCLINE MONOHYDRATE MICRONIZED

DMF 236382010

RAKS PHARMA PVT LTDDOXYCYCLINE USP

DMF 250622011

CHANGZHOU PHARMACEUTICAL FACTORYDOXYCYCLINE (ROUTE CODE: DX)

DMF 392922023

MAITHRI DRUGS PRIVATE LTDDOXYCYCLINE MONOHYDRATE USP

DMF 418462025

CHEMWERTH INCInactiveDOXYCYCLINE MONOHYDRATE

DMF 72811988

HENAN KAIFENG PHARMACEUTICAL FACTORYInactiveDOXYCYCLINE HYDROCHLORIDE

DMF 128641998

KUNSHAN ORIENTAL PHARMACEUTICAL CO LTDInactiveDOXYCYCLINE USP, NON-STERILE BULK DRUG

DMF 130401998

ANKERMAN SPAInactiveDOXYCYCLINE

DMF 134501998

WATSON LABORATORIES INCInactiveDOXYCYCLINE

DMF 135001998

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveDOXYCYCLINE USP

DMF 142951999

HENAN KAIFENG PHARMACEUTICAL FACTORYInactiveDOXYCYCLINE HYDROCHLORIDE

DMF 170942004

HUASHU PHARMACEUTICAL CORPInactiveDOXYCYCLINE MONOHYDRATE

DMF 183132005

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — EQ 50MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Mar 5, 2014

No patent or exclusivity listings for this strength.

#002 — EQ 75MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 5, 2014

#003 — EQ 100MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 5, 2014